WPRIM Management System> DCMS> Journal of Gynecologic Oncology> 2018> 29> 2

Volume: 29 Issue: 2

1. Clinical outcomes of patients with clear cell and endometrioid ovarian cancer arising from endometriosis. Page:e18—
2. Therapeutic significance of full lymphadenectomy in early-stage ovarian clear cell carcinoma. Page:e19—
3. Seromucinous component in endometrioid endometrial carcinoma as a histological predictor of prognosis. Page:e20—
4. Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility?. Page:e21—
5. Impact of institutional accreditation by the Japan Society of Gynecologic Oncology on the treatment and survival of women with cervical cancer. Page:e23—
6. Trends in single women with malignancy of the uterine cervix in United States. Page:e24—
7. Impact of adjuvant hysterectomy on prognosis in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy: a meta-analysis. Page:e25—
8. Major clinical research advances in gynecologic cancer in 2017. Page:e31—
9. The 5th Biennial Meeting of the Asian Society of Gynecologic Oncology, November 30th to December 2nd, 2017. Page:e33—
10. Trends of uterine carcinosarcoma in the United States. Page:e22—
11. Chemoresistance in ovarian cancer: exploiting cancer stem cell metabolism. Page:e32—

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.